0001655566-15-000002.txt : 20151014 0001655566-15-000002.hdr.sgml : 20151014 20151014142440 ACCESSION NUMBER: 0001655566-15-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20151014 DATE AS OF CHANGE: 20151014 EFFECTIVENESS DATE: 20151014 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sermonix Pharmaceuticals, LLC CENTRAL INDEX KEY: 0001655566 IRS NUMBER: 472551294 STATE OF INCORPORATION: OH FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-249351 FILM NUMBER: 151158065 BUSINESS ADDRESS: STREET 1: 99 NORTH BRICE ROAD, SUITE 120 CITY: COLUMBUS STATE: OH ZIP: 43213 BUSINESS PHONE: (614) 582-6849 MAIL ADDRESS: STREET 1: 99 NORTH BRICE ROAD, SUITE 120 CITY: COLUMBUS STATE: OH ZIP: 43213 D 1 primary_doc.xml X0707 D LIVE 0001655566 Sermonix Pharmaceuticals, LLC 99 NORTH BRICE ROAD, SUITE 120 COLUMBUS OH OHIO 43213 (614) 582-6849 OHIO None None Limited Liability Company true 2014 David Portman 99 North Brice Road, Suite 120 Columbus OH OHIO 43213 Executive Officer Director Miriam Portman 99 North Brice Road, Suite 120 Columbus OH OHIO 43213 Executive Officer Pharmaceuticals Decline to Disclose 06b false 2015-09-28 false true true true Offering consists of promissory notes that are convertible into equity. false 50000 3000000 1020000 1980000 false 17 0 0 0 false Sermonix Pharmaceuticals, LLC Miriam Portman Miriam Portman Chief Operating Officer 2015-10-14